Taking stock: Amyris, Solazyme, BioAmber, and Gevo spent Q1 2015 expanding market opportunities

May 14, 2015 | Analyst Insight

On May 5, 2015, Amyris announced its Q1 2015 results and noted the company ended the quarter with a positive cash flow of $1.7 million, total revenues of $7.9...